Days Inventory is also known as Days Sales of Inventory (DSI). Swedish Orphan Biovitrum AB's Average Total Inventories for the
three
months ended in Dec. 2023 was kr3,901 Mil. Swedish Orphan Biovitrum AB's Cost of Goods Sold for the
three
months ended in Dec. 2023 was kr1,387 Mil.
Hence, Swedish Orphan Biovitrum AB's Days Inventory for the
three
months ended in Dec. 2023 was 256.64.
The historical rank and industry rank for Swedish Orphan Biovitrum AB's Days Inventory or its related term are showing as below:
OSTO:SOBI'
s Days Inventory Range Over the Past 10 Years
Min: 167.23 Med: 243.43 Max: 339.28
Current: 275.87
During the past 13 years, Swedish Orphan Biovitrum AB's highest Days Inventory was 339.28. The lowest was 167.23. And the median was 243.43.
OSTO:SOBI's Days Inventory is ranked worse than 81.03% of 975
companies
in the Drug Manufacturers industry
Industry Median: 157.96
vs OSTO:SOBI: 275.87
Swedish Orphan Biovitrum AB's Days Inventory
increased
from Dec. 2022 (231.61) to Dec. 2023 (256.64).
It might indicate that Swedish Orphan Biovitrum AB's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Swedish Orphan Biovitrum AB's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Swedish Orphan Biovitrum AB's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.57.
Swedish Orphan Biovitrum AB Days Inventory Historical Data
The historical data trend for Swedish Orphan Biovitrum AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Swedish Orphan Biovitrum AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Swedish Orphan Biovitrum AB Days Inventory Distribution
For the Drug Manufacturers industry and Healthcare sector, Swedish Orphan Biovitrum AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Swedish Orphan Biovitrum AB's Days Inventory falls into.
Swedish Orphan Biovitrum AB Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Swedish Orphan Biovitrum AB's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Swedish Orphan Biovitrum AB (OSTO:SOBI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Swedish Orphan Biovitrum AB's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Swedish Orphan Biovitrum AB's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Swedish Orphan Biovitrum AB Days Inventory Related Terms
Thank you for viewing the detailed overview of Swedish Orphan Biovitrum AB's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Swedish Orphan Biovitrum AB (OSTO:SOBI) Business Description
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement programs in 2006. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016. Sobi has since been building its immunology pipeline (rare disease drug Gamifant, U.S. rights to RSV antibodies Synagis and Beyfortus, gout drug SEL-212, complement drug Aspaveli) and hematology pipeline outside of hemophilia (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:SOBI has been successfully added to your 